Argan Inc SEC Filings

Form 144 notice for ARGAN INC (AGX) reports a proposed sale of common shares by an insider through Morgan Stanley Smith Barney. The filer plans to sell 2,609 shares with an aggregate market value of $625,325.12 on the NYSE, and reports the acquisition of those shares on 09/17/2025 by exercising options under a registered plan and paying cash on the same date. The filing also discloses prior sales by the same person: 3,465 shares sold on 06/26/2025 for $734,630.59. The notice includes the seller's representation that no undisclosed material adverse information is known.

Form 144 notice for ARGAN INC (AGX) reports a proposed sale of common shares by an insider through Morgan Stanley Smith Barney. The filer plans to sell 2,609 shares with an aggregate market value of $625,325.12 on the NYSE, and reports the acquisition of those shares on 09/17/2025 by exercising options under a registered plan and paying cash on the same date. The filing also discloses prior sales by the same person: 3,465 shares sold on 06/26/2025 for $734,630.59. The notice includes the seller's representation that no undisclosed material adverse information is known.

Rainer H. Bosselmann, identified as a former CEO & Director of Argan, Inc. (AGX), filed a Form 4 reporting a disposition of 196,723 shares on 09/15/2025. The filing states this is the reporting person's final filing because he has ended service as an officer/director and is no longer subject to Section 16 reporting. The Form 4 lists Bosselmann's mailing address as Arlington, VA, and shows the filing was signed by Beverley M. Bosselmann, Attorney-in-Fact.

Rainer H. Bosselmann, identified as a former CEO & Director of Argan, Inc. (AGX), filed a Form 4 reporting a disposition of 196,723 shares on 09/15/2025. The filing states this is the reporting person's final filing because he has ended service as an officer/director and is no longer subject to Section 16 reporting. The Form 4 lists Bosselmann's mailing address as Arlington, VA, and shows the filing was signed by Beverley M. Bosselmann, Attorney-in-Fact.

Richard H. Deily, a former CFO and current officer of Argan, Inc. (AGX), reported transactions on 09/12/2025. The filing shows a sale of 7,802 shares of common stock. After the reported sale, the Form 4 lists the reporting persons remaining direct holdings in common stock attributable to outstanding equity awards: 10,000 shares underlying a 04/12/2020 option, 3,500 from a 04/16/2022 option, 2,500 from a 04/17/2024 option, 4,166 time-based RSUs scheduled to vest on 09/13/2025, and 7,500 of various performance-based RSUs/targets. The filing includes detailed vesting and payout conditions for the PRSUs and EPSRSUs with potential payouts from 0% to 200% depending on performance.

Argan, Inc. disclosed that its Board of Directors has approved a 33% increase in the regular quarterly cash dividend, raising it from $0.375 to $0.50 per common share. This higher dividend will be paid on October 31, 2025 to stockholders who are on record at the close of business on October 23, 2025. The change signals a larger ongoing cash return per share for investors through the company’s quarterly dividend program.

Argan, Inc. reports three reportable business segments and had 15,828,289 shares issued with 13,811,575 shares outstanding at July 31, 2025. The company is evaluating adoption of ASU 2023-09 on income tax disclosures. Approximately 26% of the remaining unrecognized performance obligations at July 31, 2025 are expected to be recognized in fiscal 2026, with the remainder in fiscal 2027–2029. The company has a revolving credit facility of $35.0 million priced at SOFR+1.85% with a $30.0 million accordion and a $25.0 million companion facility for letters of credit. Bonds covering warranty and retention obligations totaled $61.2 million. A $9.7 million letter of credit draw is disputed and included in accounts receivable. The IRS has disallowed R&D credits for fiscal 2021–2022; the company is contesting that finding and filed an insurance claim. Argan repurchased 56,117 shares for approximately $7.0 million during the six months ended July 31, 2025. Significant customer concentration remains in Power Industry Services, with top customers representing notable portions of revenue.

Argan, Inc. filed a current report to note that it has released financial results for the three months ended July 31, 2025. The company issued a press release on September 4, 2025 describing its results of operations and financial condition for this period.

The press release is included as Exhibit 99.1 and is incorporated by reference, while an inline XBRL cover page data file is included as Exhibit 104. The report is signed on behalf of Argan by Joshua S. Baugher, Senior Vice President, Chief Financial Officer and Treasurer.

Charles E. Collins IV, Chief Executive Officer of Argan, Inc. (AGX), reported amended insider transactions on Form 4/A. On 07/29/2025 he exercised 1,500 stock options at $46.35 and sold the same 1,500 shares on the open market at an average price of $241.50, leaving him with 22,506 shares. On 07/31/2025 he exercised 2,735 options at $46.35 and 2,265 options at $43.10, then sold 5,000 shares on the open market at an average price of $245, resulting in 21,006 shares beneficially owned following the reported transactions. The filings list option exercise dates and original grant dates and show the exercises were from options granted 01/11/2019 and 09/12/2019. The Form is signed by Mr. Collins on 08/29/2025.